Yamamoto-Furusho J K, Sarmiento-Aguilar A, Parra-Holguín N N, Bozada-Gutiérrez K E
Departamento de Gastroenterología, Clínica de Enfermedad Inflamatoria Intestinal, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Departamento de Gastroenterología, Clínica de Enfermedad Inflamatoria Intestinal, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Rev Gastroenterol Mex (Engl Ed). 2019 Jan-Mar;84(1):11-17. doi: 10.1016/j.rgmx.2018.02.003. Epub 2018 Mar 28.
During the clinical course of inflammatory bowel disease, different causes can compromise kidney, liver, and bone marrow function and increase the risk for osteoporosis, infections, and neoplasias. The aim of the present study was to describe the follow-up of Mexican patients with inflammatory bowel disease in relation to their vaccination regimen, treatment-associated risks, and cancer screening.
A retrospective cross-sectional study was conducted within the time frame of February and June 2017. One hundred patients that had a histopathologic diagnosis of inflammatory bowel disease were surveyed about their follow-up vaccination regimen, treatment-associated risks, and cancer screening. SPSS v24 software was employed for the statistical analysis.
One hundred patients with inflammatory bowel disease were studied (90% with ulcerative colitis and 10% with Crohn's disease; 60% women, 40% men): 75% stated that they had no vaccination regimen. A total of 71.4% of the women had at least one Pap smear in their lives and 28.6% did not have them done annually. Twenty-four percent of the patients wore sun block daily. A total of 18.2% of the patients with more than a 10-year progression of ulcerative colitis had an annual colonoscopy. Yearly kidney function was registered in 57.1% of the patients, 92.9% had a yearly complete blood count, and 78.6% had yearly liver function tests. A total of 34.8% of patients had no bone densitometry in their case records.
These results are a red flag suggesting the need to reinforce the role of the primary healthcare providers in relation to vaccination follow-up and the need to improve the education of the patient in relation to inflammatory bowel disease.
在炎症性肠病的临床病程中，不同原因可损害肾脏、肝脏和骨髓功能，并增加骨质疏松、感染和肿瘤的风险。本研究的目的是描述墨西哥炎症性肠病患者在疫苗接种方案、治疗相关风险和癌症筛查方面的随访情况。
于2017年2月至6月期间进行了一项回顾性横断面研究。对100例经组织病理学诊断为炎症性肠病的患者进行了关于其随访疫苗接种方案、治疗相关风险和癌症筛查的调查。采用SPSS v24软件进行统计分析。
对100例炎症性肠病患者进行了研究（90%为溃疡性结肠炎，10%为克罗恩病；60%为女性，40%为男性）：75%的患者表示没有接种疫苗方案。共有71.4%的女性一生中至少进行过一次巴氏涂片检查，28.6%的女性没有每年进行此项检查。24%的患者每天使用防晒霜。在溃疡性结肠炎病程超过10年的患者中，共有18.2%的患者每年进行结肠镜检查。57.1%的患者每年进行肾功能检查，92.9%的患者每年进行全血细胞计数检查，78.6%的患者每年进行肝功能检查。共有34.8%的患者病历中没有骨密度检查记录。
这些结果警示我们，有必要加强初级医疗服务提供者在疫苗接种随访方面的作用，并且有必要加强对炎症性肠病患者的教育。
